Skip to content
Search

Latest Stories

Over £9m worth of illegal medicines and devices seized   

Government officials have seized over three million medicines and medical devices valued at over £9m as part of a global operation tackling the illegal online sale of medicines and medical devices, the Medicines and Healthcare products Regulatory Agency (MHRA) has said.

In the UK, 113,000 illegally operating websites were also removed, or had their URLs blocked, whereas search warrants were executed, with the arrest of seven criminals.


‘Operation Pangea’, a week long action coordinated by Interpol, ran from May 18 to 25.

The operation saw over 100 countries joining forces to seize non-compliant medical products and also to identify and remove thousands of illegally operating websites and URLs offering medicines and devices.

The operation also involved coordinating the arrests of several suspected organised criminals.

The list of illegal medicines seized include anti-depressants, erectile dysfunction tablets, painkillers, anabolic steroids, and slimming pills.

Andy Morling, head of enforcement at the MHRA, said: “Criminals selling medicines and devices illegally are not only breaking the law but have no regard for your health. Taking fake or unlicensed medicines or using a non-compliant medical device could put your health and safety in danger and may lead to serious health issues.

“Operation Pangea is a powerful example of what can be achieved through partnership working to tackle this kind of offending. We will continue to work closely with our international partners and the UK Border Force to prevent unlicensed medicines from entering the UK, to identify illegally operating websites and to bring those criminals behind them to justice.”

The MHRA will be following the week of action with a detailed analysis of the global results to create a better understanding of current and emerging threats.

This work includes the identification of ‘hotspot’ exporting countries, favoured high-risk medicines being traded on the black market, and the ever-evolving business models of criminals worldwide seeking to take advantage of the public.

The MHRA’s #FakeMeds campaign aims to encourage people in the UK who choose to buy medication online to take steps to make sure they are purchasing from safe and legitimate sources.

The campaign also highlights the dangers of fake medicines sold online and the negative health effects that taking them can have. It also encourages people to report suspicious offers and any side effects experienced to the Yellow Card scheme.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less